SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-160824
Filing Date
2018-05-11
Accepted
2018-05-11 16:06:53
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d711808d10q.htm 10-Q 225832
2 EX-31.1 d711808dex311.htm EX-31.1 9629
3 EX-31.2 d711808dex312.htm EX-31.2 9630
4 EX-32.1 d711808dex321.htm EX-32.1 4574
5 EX-32.2 d711808dex322.htm EX-32.2 4575
  Complete submission text file 0001193125-18-160824.txt   1852338

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20180331.xml EX-101.INS 194004
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20180331.xsd EX-101.SCH 28702
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20180331_cal.xml EX-101.CAL 29369
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20180331_def.xml EX-101.DEF 176822
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20180331_lab.xml EX-101.LAB 246509
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20180331_pre.xml EX-101.PRE 206499
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 18826890
SIC: 2834 Pharmaceutical Preparations